中国现代医生
中國現代醫生
중국현대의생
CHINA MODERN DOCTOR
2014年
27期
24-26,29
,共4页
食管癌%胸腹腔镜%食管癌根治术%肺功能%生存率
食管癌%胸腹腔鏡%食管癌根治術%肺功能%生存率
식관암%흉복강경%식관암근치술%폐공능%생존솔
Esophageal cancer%Chest laparoscopy%Laparoscopic surgery combined thoracic%Lung function%Survival rate
目的：探讨胸腹腔镜联合食管癌根治术对食管癌患者的肺功能与生存率的影响。方法选取2011年2月~2013年2月在我院行手术治疗食管癌患者70例，其中35例行胸腹腔镜联合食管癌根治术(腔镜组)，其余35例行开胸食管癌切除术(对照组)，比较两组患者术前及术后第5天、术后2个月的肺功能指标FEV1和FVC及两组患者术后6个月、术后1年的生存率、并发症情况。结果术后2个月，两组患者的FEV1、FVC均较术前及术后第5天显著升高，且腔镜组患者术后2个月的FEV1、FVC对照组显著升高(t=2.76、2.59，P<0.05)。腔镜组患者的生存率术后6个月、术后1年虽然分别高于对照组，但差异不显著(χ2=1.753、1.982，P>0.05)。术后腔镜组患者无一例出现房颤，其并发症发生率仅8.6%，而对照组1例出现房颤，其并发症发生率达28.6%，明显高于腔镜组，差异具有显著性(χ2=4.753，P<0.05)。结论胸腹腔镜联合食管癌根治术治疗食管癌效果好，有利于改善食管癌患者的肺功能，减少术后并发症的发生率，从而提高患者的生存率。
目的：探討胸腹腔鏡聯閤食管癌根治術對食管癌患者的肺功能與生存率的影響。方法選取2011年2月~2013年2月在我院行手術治療食管癌患者70例，其中35例行胸腹腔鏡聯閤食管癌根治術(腔鏡組)，其餘35例行開胸食管癌切除術(對照組)，比較兩組患者術前及術後第5天、術後2箇月的肺功能指標FEV1和FVC及兩組患者術後6箇月、術後1年的生存率、併髮癥情況。結果術後2箇月，兩組患者的FEV1、FVC均較術前及術後第5天顯著升高，且腔鏡組患者術後2箇月的FEV1、FVC對照組顯著升高(t=2.76、2.59，P<0.05)。腔鏡組患者的生存率術後6箇月、術後1年雖然分彆高于對照組，但差異不顯著(χ2=1.753、1.982，P>0.05)。術後腔鏡組患者無一例齣現房顫，其併髮癥髮生率僅8.6%，而對照組1例齣現房顫，其併髮癥髮生率達28.6%，明顯高于腔鏡組，差異具有顯著性(χ2=4.753，P<0.05)。結論胸腹腔鏡聯閤食管癌根治術治療食管癌效果好，有利于改善食管癌患者的肺功能，減少術後併髮癥的髮生率，從而提高患者的生存率。
목적：탐토흉복강경연합식관암근치술대식관암환자적폐공능여생존솔적영향。방법선취2011년2월~2013년2월재아원행수술치료식관암환자70례，기중35례행흉복강경연합식관암근치술(강경조)，기여35례행개흉식관암절제술(대조조)，비교량조환자술전급술후제5천、술후2개월적폐공능지표FEV1화FVC급량조환자술후6개월、술후1년적생존솔、병발증정황。결과술후2개월，량조환자적FEV1、FVC균교술전급술후제5천현저승고，차강경조환자술후2개월적FEV1、FVC대조조현저승고(t=2.76、2.59，P<0.05)。강경조환자적생존솔술후6개월、술후1년수연분별고우대조조，단차이불현저(χ2=1.753、1.982，P>0.05)。술후강경조환자무일례출현방전，기병발증발생솔부8.6%，이대조조1례출현방전，기병발증발생솔체28.6%，명현고우강경조，차이구유현저성(χ2=4.753，P<0.05)。결론흉복강경연합식관암근치술치료식관암효과호，유리우개선식관암환자적폐공능，감소술후병발증적발생솔，종이제고환자적생존솔。
Objective To investigate the effects and the impact on lung function and survival rate of laparoscopic surgery combined thoracic for patients with esophageal carcinoma. Methods From February 2011 to February 2013 in our hospital,selected 70 cases patients with esophageal cancer, 35 patients took laparoscopic surgery combined tho-racic as laparoscopy group, and the remaining 35 patients took esophageal chest resection as control group , before and after surgery the first five days, lung function after two months of forced expiratory volume in 1 second (FEV1) and forced vital capacity(FVC)and two groups of patients undergoing after six months, one year survival rate after surgery, postoperative complication rate case were compared between two groups. Results After two months, the two groups of patients with FEV1, FVC significantly increased than before the surgery and the first five days after surgery, and the laparoscopic group patients of FEV1, FVC significantly higher than the control group, the difference was statistically significant(t=2.76,2.59, P<0.05). The survival rate of patients after endoscopic six months, respectively, after 1 year al-though higher, but the difference was not significant (χ2=1.753,1.982, P>0.05). None of the patients with postoperative atrial fibrillation laparoscopy group, the complication rate of only 8.6%, while the control group 1 patients had atrial fibrillation, the complication rate was 28.6%, was significantly higher than the laparoscopic group, the complications the incidence between two groups, the difference was statistically significant(χ2=4.753, P<0.05). Conclusion Laparoscopic surgery combined thoracic can help to improve lung function in patients with esophageal cancer , and reduce the inci-dence of postoperative complications, thereby improving patient survival .
